Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading AVROBIO, Inc. chart...

About the Company

We do not have any company description for AVROBIO, Inc. at the moment.

Exchange

Nasdaq

$80M

Total Revenue

95

Employees

$55M

Market Capitalization

9.99

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AVRO News

Avrobio (NASDAQ: AVRO)

8d ago, source: The Motley Fool

Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare ...

AVROBIO Inc.

10d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

AVROBIO, Inc. (AVRO) Stock Historical Prices & Data - Yahoo Finance

9d ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

North American Morning Briefing: Investors -2-

28d ago, source: Morningstar

Powered by Kantar Media and Dow Jones. Expected Earnings for Thursday AVROBIO Inc (AVRO) is expected to report $-0.43 for 4Q. Academy Sports & Outdoors Inc (ASO) is expected to report $2.29 for 4Q.

AVROBIO to Explore Strategic Alternatives

1mon ago, source: ADVFN

AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that it has completed a review of its ...

ASMB Assembly Biosciences, Inc.

3d ago, source: Seeking Alpha

Assembly Biosciences, Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company’s ...

Joshua Resnick's Net Worth

15d ago, source: Benzinga.com

Joshua Resnick has an estimated net worth of $37.6 Million. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., Vor Biopharma Inc., Aerovate ...

SYRE Spyre Therapeutics, Inc.

7d ago, source: Seeking Alpha

Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human ...

AVROBIO, Inc. (AVRO)

3d ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

AVROBIO, Inc. (AVRO)

29d ago, source: Yahoo Finance

Here is how AVROBIO, Inc. (AVRO) and Crinetics Pharmaceuticals, Inc. (CRNX) have performed compared to their sector so far this year. Here is how AVROBIO, Inc. (AVRO) and DaVita HealthCare (DVA) have ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...